Screener
Vor Biopharma VOR Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
FAQ
- What is Vor Biopharma's net income?
- Vor Biopharma (VOR) reported net income of -$219.59M in Q1 2026.
- How has Vor Biopharma's net income changed year-over-year?
- Vor Biopharma's net income decreased by 575.9% year-over-year, from -$32.49M to -$219.59M.
- What is the long-term trend for Vor Biopharma's net income?
- Over 3 years (2021 to 2024), Vor Biopharma's net income has grown at a 19.3% compound annual growth rate (CAGR), from -$68.9M to -$116.91M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Vor Biopharma's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude